☆ 4.7 Review

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients

Joschka Hey et al.

Summary: This study found that the accumulation of myeloid cells, particularly tumor-associated macrophages, characterizes the tumor microenvironment of many solid cancers, including breast cancer. The presence of cancer cells significantly alters the DNA methylation landscape of macrophages and monocytes. These results suggest that the presence of breast cancer perturbs the epigenetic landscapes of macrophages and monocytes.

INTERNATIONAL JOURNAL OF CANCER (2023)

Add to Collection

Review Biochemistry & Molecular Biology

An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer

Domenico Tierno et al.

Summary: This review summarizes the potential of circulating tumor nucleic acids (ctNAs) analysis in aiding the diagnosis and prognosis of triple-negative breast cancer (TNBC). Mutations and copy number variations of TP53 and PIK3CA/AKT genes in plasma may serve as important markers for TNBC onset, progression, metastasis, and clinical follow-up. The expression profile of circulating tumor non-coding RNAs (ctncRNAs) can predict molecular subtypes of breast cancer and aid in the identification of TNBC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype

Wenfeng Zeng et al.

Summary: This study reveals that CCL18 secreted by TAMs activates a CD10(+)GPR77(+) CAF phenotype in NBFs, leading to the enrichment of CSCs and chemoresistance in breast cancer cells. Mechanistically, CCL18 activates NF-kappa B signaling via PITPNM3 and enhances IL-6 and IL-8 production. Targeting CCL18 with anti-CCL18 antibody inhibits the formation of CD10(+)GPR77(+) CAFs and restores chemosensitivity, effectively controlling tumors.

ONCOGENE (2023)

Add to Collection

Review Oncology

Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome

Liying Li et al.

Summary: For decades, efforts have been made to develop targeted drugs for triple-negative breast cancer (TNBC), and immunotherapy has emerged as a promising approach. However, there are still gaps to be addressed. This review will analyze current immunotherapy strategies in TNBC, summarize the clinical trials landscape, and discuss future developments.

CANCERS (2023)

Add to Collection

Article Oncology

The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment

Giuseppina Augimeri et al.

Summary: Triple-negative breast cancer (TNBC), lacking effective targeted therapies, can be attenuated by DHEA through reducing cell migration, invasion, and metabolic activity. In addition, DHEA suppresses macrophage recruitment by reducing CCL5 secretion from TNBC cells, providing a potential treatment option against TNBC.

CANCERS (2023)

Add to Collection

Review Pharmacology & Pharmacy

Potential Nanotechnology-Based Therapeutics to Prevent Cancer Progression through TME Cell-Driven Populations

Rafia Ali et al.

Summary: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a high risk of metastasis and therapeutic resistance. Targeting the tumor microenvironment (TME) using nanoparticles is a promising approach to improve treatment outcomes. Various nanotherapeutics have been investigated to mitigate microenvironment-induced angiogenesis, therapeutic resistance, and tumor progression.

PHARMACEUTICS (2023)

Add to Collection

Review Cell Biology

Cancer-associated fibroblasts: The chief architect in the tumor microenvironment

Mrinmoy Sarkar et al.

Summary: Stromal heterogeneity of tumor microenvironment (TME) is crucial for malignancy and therapeutic resistance. Cancer-associated fibroblasts (CAFs) play a significant role in the tumor stroma, posing challenges to current therapies for breast cancer and other types of cancer. The positive feedback loop between CAFs and cancer cells contributes to the establishment of malignancy and reduces the efficacy of anti-cancer treatments. Understanding CAF-induced therapeutic resistance is important for improving cancer therapy outcomes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Theranostics for Triple-Negative Breast Cancer

Hyeryeon Choi et al.

Summary: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Current treatment options are limited and variable response to chemotherapy exists due to disease heterogeneity. This review discusses FDA-approved targeted therapies for TNBC, as well as novel theranostic approaches using nanocarriers. These approaches aim to improve diagnosis and treatment of TNBC by enabling targeted drug delivery and visualization of the lesion.

DIAGNOSTICS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges

Krisida Cerma et al.

Summary: Breast cancer is the most common and deadliest cancer in women, and new drugs often have limited clinical benefits. Mutations in the PI3K/AKT/mTOR pathway are frequent in breast cancer and contribute to aggressive tumor behavior and treatment resistance. Understanding the role of PI3K-mTORC1/C2 mutations in different breast cancer subtypes is crucial for improving clinical outcomes and treatment efficacy. A broad knowledge of tumor biology will be essential for personalized breast cancer therapy in the era of precision medicine.

BIOMEDICINES (2023)

Add to Collection

Article Cell Biology

Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6

Zhaoze Guo et al.

Summary: Cancer-associated fibroblasts (CAFs) are the most common stromal cells in breast cancer, and they play a role in disease progression and chemoresistance. This study found that CAF-derived conditioned media can promote breast cancer cell growth and radioresistance. The secretion of interleukin 6 (IL-6) by CAFs activates the STAT3 signaling pathway, leading to the growth and radioresistance of breast cancer cells. Inhibition of STAT3 or neutralizing IL-6 can block the effects induced by CAFs. In mouse models, the IL-6 receptor monoclonal antibody tocilizumab can reverse CAF-induced growth and radioresistance. Additionally, poor response to radiotherapy in breast cancer is associated with the expression of IL-6 and p-STAT3. These findings highlight the importance of the IL-6/STAT3 signaling pathway as a potential therapeutic target in breast cancer radiotherapy.

CELL DEATH DISCOVERY (2023)

Add to Collection

Article Oncology

Inositol monophosphatase 1 (IMPA1) promotes triple-negative breast cancer progression through regulating mTOR pathway and EMT process

Shao-Ying Yang et al.

Summary: This study reports the upregulation of IMPA1 in TNBC and its role in proliferation, metastasis and tumor formation in TNBC cells. Transcriptome sequencing analysis reveals that IMPA1 induces mTOR activity and epithelial-mesenchymal transition (EMT) process, thus promoting TNBC progression.

CANCER MEDICINE (2023)

Add to Collection

Article Oncology

Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance

Shinya Sato et al.

Summary: Bone metastasis is a common occurrence in cancer patients, and it is crucial to explore the mechanisms of cancer progression in order to develop effective therapies. In this study, the role of bone marrow adipocytes in cancer cells was investigated, revealing that they create a favorable tumor microenvironment for cancer invasion and therapeutic resistance through the induction of cancer-associated fibroblasts (CAFs) and immune evasion. These findings provide a potential target for the treatment of bone metastasis.

CANCER SCIENCE (2023)

Add to Collection

Article Cell Biology

Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation

Siqiaozhi Li et al.

Summary: The study discusses the regulatory network of Fbxo22 in triple-negative breast cancer (TNBC). It is found that Fbxo22 suppresses tumorigenesis by ubiquitination of KDM5A and regulation of p16 expression, leading to DNA damage induction. These findings contribute to a better understanding of the pathogenesis of TNBC.

CELL BIOLOGY AND TOXICOLOGY (2023)

Add to Collection

Article Oncology

Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Breast Cancer

Peng Peng et al.

Summary: Through a phenotypic screen of TNBC cells, a novel multiple kinase inhibitor tinengotinib was discovered, which strongly inhibits various kinases including Aurora A/B, FGFR1/2/3, VEGFRs, JAK1/2, and CSF1R. Tinengotinib specifically inhibited proliferation of all TNBC subtypes in vitro and in vivo, while leaving luminal breast cancer cells intact. Mechanistically, tinengotinib primarily inhibits Aurora A or B kinase activity, while inhibition of other pathways contributes to its potency and activity. Moreover, tinengotinib treatment resulted in up-regulation of CXCL10 and 11 or reduced tumor-associated macrophage (TAM) infiltration in TNBC cell lines or a syngeneic model. The phase I trial of tinengotinib has been completed (ClinicalTrials.gov identifier: NCT03654547).

MOLECULAR CANCER THERAPEUTICS (2023)

Add to Collection

Article Cell Biology

Immature natural killer cells promote progression of breast cancer

Gatha Thacker et al.

Summary: Using single-cell RNA sequencing and functional analysis, a unique population of Socs3(high)CD11b(-)CD27(-) immature NK cells was identified in triple-negative breast cancer (TNBC) samples. These NK cells activated cancer stem cells through Wnt signaling, promoting tumor progression. Depletion of NK cells or inhibition of Wnt ligand secretion from NK cells reduced tumor progression. Furthermore, depletion of NK cells or inhibition of their function enhanced the response to anti-PD-L1 antibody or chemotherapy in TNBC mice.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Add to Collection

Review Medicine, General & Internal

Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)

Jieun Lee

Summary: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer, accounting for 15-20% of cases, with a high rate of recurrence despite chemotherapy. Conventional cytotoxic chemotherapy with anthracyclines and taxanes remains the main treatment option. Achievement of pathologic complete response (pCR) is associated with improved survival outcomes, leading to the shift towards neoadjuvant treatment and investigation of intensified chemotherapy and post-neoadjuvant therapy. This article reviews the current treatment landscape for early TNBC, from standard cytotoxic chemotherapy to immune checkpoint inhibitors, capecitabine, and olaparib.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Reprogrammed Glucose Metabolism in Cancer

Meran Keshawa Ediriweera et al.

Summary: Cancer cells reprogram their metabolism to support their growth and survival. Reprogrammed glucose metabolism promotes key characteristics of cancer and enzymes involved in glycolysis can be targeted for anti-cancer treatments. This review summarizes the role of reprogrammed glucose metabolism in cancer cells and discusses its potential for manipulating tumor growth.

METABOLITES (2023)

Add to Collection

Review Oncology

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials

Chenxi Li et al.

Summary: The combination of PARP inhibitors and chemotherapy appears to be more effective in treating triple-negative breast cancer than chemotherapy alone, but it is associated with a higher rate of adverse events that should be taken seriously.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer

Wanda Marini et al.

Summary: Compared with other breast cancer subtypes, triple negative breast cancer (TNBC) is more aggressive and has a higher recurrence rate and lower overall survival. Notch signaling drives the expression of IL1 beta and CCL2 in TNBC, resulting in the recruitment of TAMs and immune evasion. Targeting Notch, IL1 beta, or CCL2 may reduce TAM recruitment and resistance to ICIs, suggesting the potential of combination immunotherapy in TNBC.

DNA AND CELL BIOLOGY (2023)

Add to Collection

Review Medicine, Research & Experimental

Hypoxia signaling in cancer: Implications for therapeutic interventions

Yan Zhuang et al.

Summary: Hypoxia is a persistent physiological feature of solid tumors, driving malignancy and reducing the effectiveness of other tumor therapies. The critical role of hypoxia in tumor development, including metabolism, immunity, and angiogenesis, is discussed. Treatment methods for hypoxic tumor microenvironment, including hypoxia-targeted therapy and improving oxygenation, are summarized in this review.

MEDCOMM (2023)

Add to Collection

Review Oncology

Role of Natural and Synthetic Flavonoids as Potential Aromatase Inhibitors in Breast Cancer: Structure-Activity Relationship Perspective

Umang Shah et al.

Summary: Breast cancer is a common and challenging cancer in females worldwide. Estrogen and its metabolites play a significant role in the development of breast cancer. Aromatase inhibitors have been used clinically to suppress estrogen, but modifying the structure of natural and synthetic flavonoids may lead to the design of a novel inhibitor. This review explores the structure-activity relationship of flavonoids and their potential in designing a lead candidate for breast cancer treatment in the future.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Oncology

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

Zhen Shi et al.

Summary: This study demonstrates the association between high baseline pAKT levels, mutations in PI3K/AKT pathway components, and the enriched benefit of ipatasertib in TNBC.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Review Oncology

The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer

Danny Yu Jia Ke et al.

Summary: Triple-negative breast cancer (TNBC) is a type of breast cancer that lacks targeted therapy receptors, making chemotherapy the main treatment option. However, the enrichment of cancer stem cells (CSCs) contributes to treatment resistance and tumor recurrence. Natural compounds derived from plants have the potential to target CSCs and improve TNBC treatment efficacy. Clinical trials have shown varying degrees of effectiveness, and further research is needed.

CURRENT CANCER DRUG TARGETS (2022)

Add to Collection

Review Medicine, Research & Experimental

Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular Medicine

Suman Kumar Ray et al.

Summary: Epigenetics plays a significant role in the development and progression of triple-negative breast cancer, affecting tumor behavior through changes in cell plasticity and gene expression profiles. The latest developments in transcriptomics have improved our understanding of the disease and have the potential for use in diagnosis, prognosis, and treatment decisions.

CURRENT MOLECULAR MEDICINE (2022)

Add to Collection

Article Plant Sciences

Natural Prenylated Xanthones as Potential Inhibitors of PI3k/Akt/mTOR Pathway in Triple Negative Breast Cancer Cells

Thi Thu Ha Nguyen et al.

Summary: Three prenylated xanthones were isolated from Garcinia mckeaniana leaves and their structures were determined. These xanthones exhibited inhibitory effects on TNBC cell proliferation and induced apoptosis, with compound 2 potentially downregulating PI3K, Akt, and mTOR levels.

PLANTA MEDICA (2022)

Add to Collection

Review Oncology

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer

Yiqi Fan et al.

Summary: Triple-negative breast cancer (TNBC) is a unique subtype of breast cancer with high intrinsic heterogeneity and a distinct immune microenvironment. Understanding the TNBC microenvironment is crucial for the prognosis and treatment of this disease.

CANCER MANAGEMENT AND RESEARCH (2022)

Add to Collection

Review Oncology

Epigenetic Therapies and Biomarkers in Breast Cancer

Lauren Julia Brown et al.

Summary: Epigenetic therapies are promising but not widely used in the management of breast cancer. The most studied treatments target DNA methylation and histone modification, but none have been approved for routine clinical use. Combination therapies may be more effective in breast cancer treatment. With advancing technology, more potential epigenetic biomarkers for treatment response are being identified.

CANCERS (2022)

Add to Collection

Article Oncology

Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy

Shuo Zhang et al.

Summary: This study investigated the effect of Radix Tetrastigma extracts (RTEs) on Taxol-induced autophagy and chemosensitivity in triple-negative breast cancer (TNBC). The results showed that RTEs enhanced the chemosensitivity of resistant TNBC cells to Taxol by inhibiting PI3K/Akt/mTOR-mediated autophagy.

CLINICAL BREAST CANCER (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Epigenetics of Triple-Negative Breast Cancer via Natural Compounds

Mohammed Kaleem et al.

Summary: TNBC is a highly resistant, lethal, and metastatic subtype of breast cancer characterized by the deficiency of ER, PR, and HER2. It shows higher aggressiveness and poorer prognosis in women, with a higher recurrence rate during reproductive age. TNBC is defined by the presence of EMT and exhibits specific epigenetic markers.

CURRENT MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Gypensapogenin H suppresses tumor growth and cell migration in triple-negative breast cancer by regulating PI3K/AKT/NF-κB/MMP-9 signaling pathway

Hongyan Tan et al.

Summary: In this study, the efficacy of Gypensapogenin H (GH) in the treatment of triple-negative breast cancer (TNBC) was evaluated. The results showed that GH inhibited TNBC proliferation and migration by regulating the PI3K/AKT/NF-kappa B/MMP-9 signaling pathway. These findings provide important clues for further investigation of the mechanism of action of GH.

BIOORGANIC CHEMISTRY (2022)

Add to Collection

Article Oncology

Epigenetic drugs induce the potency of classic chemotherapy, suppress post-treatment re-growth of breast cancer, but preserve the wound healing ability of stem cells

Andrew Zheng et al.

Summary: This study investigates the effects of standard chemotherapy and epigenetic therapy on breast cancer cells and adipose stem cells. The results show that the combination of epigenetic drugs with paclitaxel has increased toxicity against breast cancer cells compared to chemotherapy alone. Furthermore, this combination has minimal effect on the wound healing ability of adipose stem cells.

CANCER BIOLOGY & THERAPY (2022)

Add to Collection

Article Chemistry, Medicinal

Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling

Wei Cheng et al.

Summary: This study found that Sophoraflavanone G (SG) can inhibit the proliferation and metastasis of triple-negative breast cancer (TNBC) by targeting the EGFR-PI3K-AKT signaling pathway, and induce cell apoptosis and oxidative stress.

DRUG DEVELOPMENT RESEARCH (2022)

Add to Collection

Article

Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures

Dharambir Kashyap et al.

Biomed Research International (2022)

Add to Collection

Article Genetics & Heredity

Histone H3 proline 16 hydroxylation regulates mammalian gene expression

Xijuan Liu et al.

Summary: Histone H3 with hydroxylation of proline at residue 16 (H3P16oh) is an important histone post-translational modification (PTM) in mammalian cells, and it regulates mammalian gene expression.

NATURE GENETICS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets

Alberto Zambelli et al.

Summary: The authors review the principal biological characteristics of TNBC, including molecular driver alterations, targetable genes, and immune biomarkers. They also summarize the landscape of biomarker-driven therapeutic options in TNBC that emerge from the unique biological basis of the disease.

EXPERT OPINION ON THERAPEUTIC TARGETS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression

Xue Yang et al.

Summary: LINC01559 is significantly upregulated in TNBC tissues and acts as a carcinogenic ceRNA by sponging miRNAs, resulting in the increased expression of oncogenes and promoting TNBC progression. Targeting LINC01559 may be a potential treatment for TNBC patients.

BIOMEDICAL JOURNAL (2022)

Add to Collection

Article Cell Biology

AMPK activator AICAR in combination with anti-mouse IL10 mAb restores the functionality of intra-tumoral Tfh cells in the 4T1 mouse model

Poulomi Khamaru et al.

Summary: This study aims to alleviate the suppressed anti-tumor immune response by improving CD4+ T follicular helper cell (Tfh) response. The results demonstrate that synergistic treatment with 2DG/Etomoxir + anti-IL10 mAb promotes Tfh cell, memory B, and GC B cell response more effectively. AICAR + anti-IL10 mAb treatment increases intratumoral Tfh cells and improves humoral response.

CELLULAR IMMUNOLOGY (2022)

Add to Collection

Review Oncology

Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer

Arpita Poddar et al.

Summary: Breast cancer, especially the triple-negative subtype, is a leading cause of death in women worldwide. While immunotherapy shows promise as a treatment option, activation of cellular plasticity programs can hinder its effectiveness.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications

Mohammad Askandar Iqbal et al.

Summary: The study shows that silibinin disrupts metabolic reprogramming in TNBC cells through modulation of the EGFR-MYC-TXNIP signaling pathway, leading to decreased cell biomass and proliferation. Silibinin inhibits glycolytic metabolism in TNBC, and combination therapy with paclitaxel yields promising results, highlighting the potential of targeting metabolic vulnerabilities in TNBC treatment.

FEBS JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy

Kartik Anand et al.

Summary: The combination therapy of everolimus and cisplatin aimed to improve the rate of pathologic response in TNBC patients, with a 23% response rate observed in those achieving RCB-I during surgery.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Genetics & Heredity

JAK2 regulates paclitaxel resistance in triple negative breast cancers

Jongmin Han et al.

Summary: Our study revealed that JAK2 signaling is associated with paclitaxel resistance in TNBC, with paclitaxel-resistant PDX tumors enriched in the cell cycle cCAF subpopulation. JAK2 was found to regulate the transition of paclitaxel-resistant CAF phenotype.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Add to Collection

Article Medicine, Research & Experimental

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer

Deanna N. Edwards et al.

Summary: Research shows an inverse correlation between glutamine metabolic genes and markers of T cell-mediated cytotoxicity in basal-like breast cancer patients, with increased glutamine metabolism associated with poor survival. Targeting glutamine metabolism selectively in tumors may be a promising therapeutic strategy for improving antitumor immune responses.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Chemistry, Medicinal

Structure-Activity-Relationship-Aided Design and Synthesis of xCT Antiporter Inhibitors

Davide Cirillo et al.

Summary: The xCT antiporter plays a crucial role in glutathione biosynthesis and can be inhibited by the medication sulfasalazine. By designing and synthesizing styryl hydroxy-benzoic acid analogues, researchers discovered a promising candidate molecule with minimal toxicity in normal human astrocytes.

CHEMMEDCHEM (2021)

Add to Collection

Article Oncology

The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer

Satoshi Okazaki et al.

Summary: This study established a high-sensitivity detection system for frequently mutated genes in TNBC patients, which was also applicable for cell-free DNA. The activation of the PI3K/AKT pathway was revealed in patients harboring PIK3CA H1047R and AKT1 E17K mutations, suggesting the potential of the PI3K/AKT pathway as a promising candidate for targeted therapy in these patients.

ONCOLOGY LETTERS (2021)

Add to Collection

Article Oncology

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

Julia Eismann et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer

K. G. K. Deepak et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Review Oncology

Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer

Mamta Kumari et al.

CURRENT CANCER DRUG TARGETS (2020)

Add to Collection

Editorial Material Oncology

T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting

Christopher J. Hanley et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Article Chemistry, Inorganic & Nuclear

Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer

Nafees Muhammad et al.

INORGANIC CHEMISTRY (2020)

Add to Collection

Review Oncology

Metabolic reprogramming in triple-negative breast cancer

Zhanyu Wang et al.

CANCER BIOLOGY & MEDICINE (2020)

Add to Collection

Article Oncology

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

Thomas J. Rogers et al.

MOLECULAR CANCER RESEARCH (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Jing Yang et al.

MOLECULAR CANCER (2019)

Add to Collection

Article Oncology

Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation

Ruoxi Hong et al.

MOLECULAR ONCOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways

Dongya Jia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Article Cell Biology

Mapping Metabolic Events in the Cancer Cell Cycle Reveals Arginine Catabolism in the Committed SG2M Phase

Irena Roci et al.

CELL REPORTS (2019)

Add to Collection

Article Oncology

Energetic Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy

Marco Fiorillo et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Article Cell Biology

Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state

Gloria V. Echeverria et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Add to Collection

Meeting Abstract Hematology

Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma

Reona Sakemura et al.

BLOOD (2019)

Add to Collection

Article Oncology

NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

Aura Muntasell et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Multidisciplinary Sciences

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype

Sadhbh O'Neill et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Oncology

Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4

Christopher J. Hanley et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Add to Collection

Article Pathology

Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer

Thomas A. Adams et al.

MODERN PATHOLOGY (2018)

Add to Collection

Article Oncology

Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4

Christopher J. Hanley et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents

Matteo Santoni et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Add to Collection

Article Oncology

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

Ana Costa et al.

CANCER CELL (2018)

Add to Collection

Article Cell Biology

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling

Ming Luo et al.

CELL METABOLISM (2018)

Add to Collection

Article Endocrinology & Metabolism

Untargeted and stable isotope-assisted metabolomic analysis of MDA-MB-231 cells under hypoxia

Jie Yang et al.

METABOLOMICS (2018)

Add to Collection

Article Multidisciplinary Sciences

Asparagine bioavailability governs metastasis in a model of breast cancer

Simon R. V. Knott et al.

NATURE (2018)

Add to Collection

Article

Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression

Filipa Lopes-Coelho et al.

TUMOR BIOLOGY (2018)

Add to Collection

Article Cell Biology

Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells

Marta Mauro-Lizcano et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Glutaminase isoenzymes in the metabolic therapy of cancer

Jose M. Mates et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Add to Collection

Article Oncology

Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

Sitai Liang et al.

MOLECULAR ONCOLOGY (2018)

Add to Collection

Article Oncology

The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

Anjana Bhardwaj et al.

BREAST CANCER RESEARCH (2018)

Add to Collection

Review Oncology

Triple negative breast cancer - prognostic role of immune-related factors: a systematic review

Elisabeth Specht Stovgaard et al.

ACTA ONCOLOGICA (2018)

Add to Collection

Article Gastroenterology & Hepatology

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer

Gemma Ferrer-Mayorga et al.

GUT (2017)

Add to Collection

Article Cell Biology

Supernatants of Adipocytes From Obese Versus Normal Weight Women and Breast Cancer Cells: In Vitro Impact on Angiogenesis

Lauriane Bougaret et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2017)

Add to Collection

Editorial Material Immunology

A Rogue Foxp3 Mutant Undermines Treg Cell Function

Ye Zheng

IMMUNITY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1

N. Cohen et al.

ONCOGENE (2017)

Add to Collection

Review Medical Laboratory Technology

Deciphering metabolic rewiring in breast cancer subtypes

Martin P. Ogrodzinski et al.

TRANSLATIONAL RESEARCH (2017)

Add to Collection

Article Oncology

Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer

In Hye Song et al.

CANCER RESEARCH AND TREATMENT (2017)

Add to Collection

Article Medicine, Research & Experimental

Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells

Mengchuan Wang et al.

MEDICAL SCIENCE MONITOR (2017)

Add to Collection

Article Oncology

Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers

Satish K. Noonepalle et al.

CANCER IMMUNOLOGY RESEARCH (2017)

Add to Collection

Article Multidisciplinary Sciences

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition

Michael Lampa et al.

PLOS ONE (2017)

Add to Collection

Article Multidisciplinary Sciences

Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis

Tieying Dong et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Cell Biology

Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence

Marcos Rios Garcia et al.

CELL METABOLISM (2017)

Add to Collection

Article Cell Biology

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Kyung-Min Lee et al.

CELL METABOLISM (2017)

Add to Collection

Review Oncology

Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance

Tianjian Yu et al.

CHINESE JOURNAL OF CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

G. Pruneri et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Oncology

CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer

Daisuke Izumi et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Add to Collection

Article Oncology

Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group

Shannon K. Swisher et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Guidelines for the selection of functional assays to evaluate the hallmarks of cancer

Otilia Menyhart et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine

Kimberly J. Briggs et al.

CELL (2016)

Add to Collection

Article Cell Biology

Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth

Lifeng Yang et al.

CELL METABOLISM (2016)

Add to Collection

Editorial Material Oncology

Obesity and Cancer: Insights for Clinicians

Pamela J. Goodwin et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling

Jaya Gautam et al.

MOLECULAR CANCER (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

Roman Camarda et al.

NATURE MEDICINE (2016)

Add to Collection

Article Multidisciplinary Sciences

Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers

Roni Allaoui et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Oncology

Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells

Masanori Hasegawa et al.

ONCOTARGET (2016)

Add to Collection

Article Oncology

Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis

Ke Wang et al.

ONCOTARGET (2016)

Add to Collection

Article Oncology

Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer

Ken Takai et al.

ONCOTARGET (2016)

Add to Collection

Article Oncology

Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo

Hyein Jeon et al.

ONCOTARGET (2016)

Add to Collection

Article Cell Biology

Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer

Jun Hyoung Park et al.

CELL REPORTS (2016)

Add to Collection

Review Multidisciplinary Sciences

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis

Yan Mao et al.

PLOS ONE (2016)

Add to Collection

Review Oncology

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting

Paula Garcia-Teijido et al.

CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2016)

Add to Collection

Article Oncology

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Giulia Bottai et al.

BREAST CANCER RESEARCH (2016)

Add to Collection

Article Cell Biology

5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells

Suman Mukhopadhyay et al.

CELL CYCLE (2015)

Add to Collection

Article Medicine, General & Internal

Effect of Rosuvastatin on Arginase Enzyme Activity and Polyamine Production in Experimental Breast Cancer

Hakan Erbas et al.

BALKAN MEDICAL JOURNAL (2015)

Add to Collection

Review Oncology

Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion

Hideki Yamaguchi et al.

CANCERS (2015)

Add to Collection

Article Oncology

Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue

Patricia Casbas-Hernandez et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Add to Collection

Article Cell Biology

Loss of GLUT4 Induces Metabolic Reprogramming and Impairs Viability of Breast Cancer Cells

Pablo Garrido et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

Meihua Chen et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Oncology

Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

Minoru Miyashita et al.

BREAST CANCER RESEARCH (2015)

Add to Collection

Article Oncology

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

M. V. Dieci et al.

ANNALS OF ONCOLOGY (2014)

Add to Collection

Article Oncology

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

S. Loi et al.

ANNALS OF ONCOLOGY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome

J. Doyen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Add to Collection

Article Oncology

Metabolic characterization of triple negative breast cancer

Maria D. Cao et al.

BMC CANCER (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy

Mara H. Sherman et al.

CELL (2014)

Add to Collection

Review Multidisciplinary Sciences

The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis

Yan Mao et al.

PLOS ONE (2014)

Add to Collection

Review Oncology

Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth

Ubaldo E. Martinez-Outschoorn et al.

SEMINARS IN CANCER BIOLOGY (2014)

Add to Collection

Review Oncology

Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Simran S. Sabharwal et al.

NATURE REVIEWS CANCER (2014)

Add to Collection

Article Oncology

Prognostic impact of FOXP3 expression in triple-negative breast cancer

Soohyeon Lee et al.

ACTA ONCOLOGICA (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors

Neta Erez et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Add to Collection

Article Oncology

Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer

N. R. West et al.

BRITISH JOURNAL OF CANCER (2013)

Add to Collection

Article Oncology

Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Luika A. Timmerman et al.

CANCER CELL (2013)

Add to Collection

Review Biochemistry & Molecular Biology

Tumor glycolysis as a target for cancer therapy: progress and prospects

Shanmugasundaram Ganapathy-Kanniappan et al.

MOLECULAR CANCER (2013)

Add to Collection

Review Oncology

Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer

Yuan-Yuan Wang et al.

CANCER LETTERS (2012)

Add to Collection

Article Cell Biology

Using the reverse Warburg effect to identify high-risk breast cancer patients Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers

Agnieszka K. Witkiewicz et al.

CELL CYCLE (2012)

Add to Collection

Article Medicine, Research & Experimental

A metabolic prosurvival role for PML in breast cancer

Arkaitz Carracedo et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Add to Collection

Article Pathology

Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer Implication for Retinoic Acid Therapy

Rong-Zong Liu et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Add to Collection

Article Oncology

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

Sirkku Pollari et al.

BREAST CANCER RESEARCH AND TREATMENT (2011)

Add to Collection

Article Oncology

CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

Fangfang Liu et al.

BREAST CANCER RESEARCH AND TREATMENT (2011)

Add to Collection

Article Oncology

CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth

Takatsugu Ishimoto et al.

CANCER CELL (2011)

Add to Collection

Article Oncology

Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion

Beatrice Dirat et al.

CANCER RESEARCH (2011)

Add to Collection

Editorial Material Cell Biology

Metabolic cues from the microenvironment act as a major selective factor for cancer progression and metastases formation

Jacinta Serpa et al.

CELL CYCLE (2011)

Add to Collection

Article Cell Biology

Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth Understanding the aging and cancer connection

Renee M. Balliet et al.

CELL CYCLE (2011)

Add to Collection

Article Cell Biology

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress

Kathrin Zaugg et al.

GENES & DEVELOPMENT (2011)

Add to Collection

Article Developmental Biology

Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

Damya Laoui et al.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)

Add to Collection

Article Oncology

Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers

J. Terese Camp et al.

MOLECULAR CANCER RESEARCH (2011)

Add to Collection

Article Genetics & Heredity

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

Jason W. Locasale et al.

NATURE GENETICS (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Macrophage Diversity Enhances Tumor Progression and Metastasis

Bin-Zhi Qian et al.

CELL (2010)

Add to Collection

Article Medicine, Research & Experimental

Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model

Jadwiga Jablonska et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Add to Collection

Article Immunology

Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells

Srinivas Nagaraj et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection

Review Biotechnology & Applied Microbiology

Targeting the phosphoinositide 3-kinase pathway in cancer

Pixu Liu et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Add to Collection

Article Hematology

L-arginine availability regulates T-lymphocyte cell-cycle progression

Paulo C. Rodriguez et al.

BLOOD (2007)

Add to Collection

Article Oncology

Adaptation of energy metabolism in breast cancer brain metastases

Emily I. Chen et al.

CANCER RESEARCH (2007)

Add to Collection

Article Oncology

Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse

Gaynor J. Bates et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Add to Collection

Article Cell Biology

Stromal fibroblasts in cancer - A novel tumor-promoting cell type

Akira Orimo et al.

CELL CYCLE (2006)

Add to Collection

Review Cell Biology

Leptin and cancer

C Garofalo et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2006)

Add to Collection

Review Oncology

Role of tumor-associated macrophages in tumor progression and invasion

Alberto Mantovani et al.

CANCER AND METASTASIS REVIEWS (2006)

Add to Collection

Article Oncology

Breast cancer cells stimulate neutrophils to produce oncostatin M: Potential implications for tumor progression

MM Queen et al.

CANCER RESEARCH (2005)

Add to Collection

Article Oncology

Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer

M Ishikawa et al.

CLINICAL CANCER RESEARCH (2004)

Add to Collection

Article Immunology

Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages

A Sica et al.

JOURNAL OF IMMUNOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.